Is a complete BCYC research report available?

No complete published report is available for Bicycle Therapeutics plc (BCYC) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Bicycle Therapeutics plc (BCYC)

NASDAQ: BCYC · USD

$4.01

+0.15 (+3.9%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first BCYC analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	279.9M
Revenue (ttm)	63.5M
Net income (ttm)	-219M
EPS (ttm)	-$3.16
Shares out	69.8M
Volume	418,936
Beta	1.55
Price target	$13.6	+238.4%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 63.5M
Net income (ttm): -219M
EPS (ttm): -$3.16
Market cap: 279.9M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All BCYC indicators

Market & fundamental data

Available fields

207

Groups with data

Currency

USD

Showing 207 of 207 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001761612
Company name	Bicycle Therapeutics plc
Country	United Kingdom
Country code	US
Cusip	088786108
Employees	288
Employees Change	-17%
Employees Change Percent	-5.57
Enterprise value	$-264.2M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2019-05-23
Isin	US0887861088
Last refreshed	2026-07-31
Market cap	$279.9M
Market cap category	Micro-Cap
Price	$4.01
Price currency	USD
Rev Per Employee	220,472.22x
Sector	Healthcare
Sector PE	45.21
Sector PE Fwd	23.64
Sic	2834
Symbol	BCYC
Website	https://www.bicycletherapeutics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-78.24%
FCF yield	-82.76%
P/B ratio	0.49x
P/S ratio	4.41x
PS Forward	18.91x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-343.6%
EBITDA Margin	-334.96%
Gross margin	-244.54%
Gross Profit	$-155.3M
Net Income	$-219M
Net Income Growth Years	0%
Pretax Margin	-342.73%
Profit Per Employee	$-760,524
ROA	-19.38
Roa5y	-17.54
ROCE	-34.85
ROE	-33.84
Roe5y	-36.67
ROIC	-22.58

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-52.96%
Cagr3y	-45.41%
Cagr5y	-33.66%
EPS Growth Quarters	2
EPS Growth Years	0
Revenue Growth	146.86x
Revenue Growth Q	-91.11x
Revenue Growth Years	5x
Revenue Growth3 Y	60.01x
Revenue Growth5 Y	41.82x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.08
Assets	$652.4M
Cash	$559.5M
Current Assets	$619.1M
Current Liabilities	$48.9M
Debt	$15.3M
Debt Equity	$0.03
Equity	$554.3M
Interest Coverage	-1,036
Liabilities	$98.1M
Long Term Assets	$33.3M
Long Term Liabilities	$49.2M
Net Cash	$544.1M
Net Cash By Market Cap	$194
Net Cash Growth	-30.65%
Net Debt Equity	$-0.98
Tangible Book Value	$554.3M
Tangible Book Value Per Share	$7.95
WACC	12.17

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	12.66
Net Working Capital	$12.2M
Quick ratio	12.28
Working Capital	$570.2M
Working Capital Turnover	$0.09

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-6.99%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-52.93%
200-day SMA	5.63
3Y total return	-83.74%
50-day SMA	4.21
50-day SMA vs 200-day SMA	50under200
5Y total return	-87.14%
All Time High	62.08
All Time High Change	-93.54%
All Time High Date	2021-11-15
All Time Low	3.81
All Time Low Change	5.25%
All Time Low Date	2026-07-30
ATR	0.18
Beta	1.55
Beta1y	2.17
Beta2y	1.86
Ch YTD	-43.36
High	4.03
High52	9.16
High52 Date	2025-10-09
High52ch	-56.22%
Low	3.81
Low52	3.81
Low52 Date	2026-07-30
Low52ch	5.25%
Ma50ch	-4.77%
Premarket Change Percent	-0.26
Premarket Price	$3.85
Premarket Volume	2,177
Price vs 200-day SMA	-28.74%
RSI	43.98
RSI Monthly	29.74
RSI Weekly	36.43
Sharpe ratio	-1.29x
Sortino ratio	-1.6
Total Return	-6.99%
Tr YTD	-43.36
Tr1m	-3.37%
Tr1w	-3.61%
Tr3m	-15.22%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	9
Analyst Count Top	7
Analyst Price Target Top	$14.33
Analyst Ratings	Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.53
Earnings Revenue Estimate	5,419,200x
Earnings Revenue Estimate Growth	85.59x
Operating Income	$-238.1M
Operating margin	-375.1
Price target	$13.57
Price Target Change	$238
Price Target Change Top	$257

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Net Borrowing	-191,000
Shares Insiders	1.28%
Shares Institutions	40.72%
Shares Out	69,811,225
Shares Qo Q	0.46%
Shares Yo Y	6.99%
Short Ratio	4.77
Short Shares	7.67

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-268.5M
Adjusted OCF	-266,019,000
Average Volume	346,954.45x
Bv Per Share	7.95
CAPEX	$-2.5M
Ch1m	-3.37
Ch1w	-3.61
Ch1y	-52.93
Ch3m	-15.22
Ch3y	-83.74
Ch5y	-87.14
Ch6m	-38.5
Change	3.89%
Change From Open	3.89
Close	3.86
Days Gap	0
Depreciation Amortization	5,917,000
Dollar Volume	1,679,933.4
Earnings Date	2026-07-30
Earnings Time	bmo
EBIT	$-210.3M
EBITDA	$-205M
EPS	$-3.16
F Score	2
FCF	$-231.7M
FCF EV Yield	87.7x
FCF Per Share	$-3.32
Financing CF	-144,000
Fiscal Year End	December
Founded	2,009
Income Tax	$1.4M
Investing CF	-2,459,000
Ipr	-71.36
Iprfo	-70.01
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-07-30
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-17
Ma150	5.08
Ma150ch	-21.05%
Ma20	4.17
Ma20ch	-3.88%
Net CF	-233,441,000
Next Earnings Date	2026-10-29
Open	3.86
Optionable	Yes
Position In Range	90.91
Post Close	4.01
Postmarket Change Percent	0.25
Postmarket Price	$4.02
Ppne	20,269,000
Pre Close	3.86
Price Date	2026-07-30
Ptbv Ratio	0.51
Relative Volume	1.21x
Revenue	63,496,000x
SBC By Revenue	57.94x
Share Based Comp	36,789,000
Tax By Revenue	2.22x
Tr6m	-38.5%
Volume	418,936
Z Score	0.92

Bicycle Therapeutics plc (BCYC)

Coverage state: Market snapshot only — no published research

Generate the first BCYC analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · BCYC

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BCYC indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on BCYC

Frequently asked questions